Compare ESTA & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | FMC |
|---|---|---|
| Founded | 2004 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2018 | 1994 |
| Metric | ESTA | FMC |
|---|---|---|
| Price | $66.04 | $14.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $86.86 | $18.50 |
| AVG Volume (30 Days) | 456.5K | ★ 2.7M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ 42.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $61,208,000.00 | ★ $4,727,800,000.00 |
| Revenue This Year | $28.05 | $7.89 |
| Revenue Next Year | $26.21 | $4.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $33.35 | $12.17 |
| 52 Week High | $83.31 | $44.77 |
| Indicator | ESTA | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 45.01 |
| Support Level | $63.36 | $14.04 |
| Resistance Level | $69.23 | $14.55 |
| Average True Range (ATR) | 4.36 | 0.77 |
| MACD | -0.29 | -0.11 |
| Stochastic Oscillator | 34.35 | 38.10 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.